OBJECTIVE: This study was aimed at assessing the dynamics of vitronectin (VN), laminin (LN), and heparan sulfate/heparin (HS/HP) content changes during experimental burn healing. METHODS: VN, LN, and HS/HP were isolated and purified from normal and injured skin of domestic pigs, on the 3rd, 5th, 10th, 15th, and 21st days following thermal damage. The wounds were treated with apitherapeutic agent (propolis), silver sulfadiazine (SSD), physiological salt solution, and propolis vehicle. VN and LN were quantified using an immunoenzymatic assay and HS/HP was estimated by densitometric analysis. RESULTS: Propolis treatment stimulated significant increases in VN, LN, and HS/HP contents during the initial phase of study, followed by a reduction in the estimated extracellular matrix molecules. Similar patterns, although less extreme, were observed after treatment with SSD. CONCLUSIONS: The beneficial effects of propolis on experimental wounds make it a potential apitherapeutic agent in topical burn management.
OBJECTIVE: This study was aimed at assessing the dynamics of vitronectin (VN), laminin (LN), and heparan sulfate/heparin (HS/HP) content changes during experimental burn healing. METHODS: VN, LN, and HS/HP were isolated and purified from normal and injured skin of domestic pigs, on the 3rd, 5th, 10th, 15th, and 21st days following thermal damage. The wounds were treated with apitherapeutic agent (propolis), silver sulfadiazine (SSD), physiological salt solution, and propolis vehicle. VN and LN were quantified using an immunoenzymatic assay and HS/HP was estimated by densitometric analysis. RESULTS: Propolis treatment stimulated significant increases in VN, LN, and HS/HP contents during the initial phase of study, followed by a reduction in the estimated extracellular matrix molecules. Similar patterns, although less extreme, were observed after treatment with SSD. CONCLUSIONS: The beneficial effects of propolis on experimental wounds make it a potential apitherapeutic agent in topical burn management.
Authors: Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask Journal: Am J Pathol Date: 2005-12 Impact factor: 4.307
Authors: Pawel Olczyk; Katarzyna Komosinska-Vassev; Katarzyna Winsz-Szczotka; Jerzy Stojko; Katarzyna Klimek; Ewa M Kozma Journal: Evid Based Complement Alternat Med Date: 2013-03-07 Impact factor: 2.629
Authors: Pawel Olczyk; Pawel Ramos; Katarzyna Komosinska-Vassev; Jerzy Stojko; Barbara Pilawa Journal: Evid Based Complement Alternat Med Date: 2013-05-23 Impact factor: 2.629
Authors: Paweł Olczyk; Robert Koprowski; Justyna Kaźmierczak; Lukasz Mencner; Robert Wojtyczka; Jerzy Stojko; Krystyna Olczyk; Katarzyna Komosinska-Vassev Journal: Evid Based Complement Alternat Med Date: 2016-05-18 Impact factor: 2.629
Authors: Paweł Olczyk; Pawel Ramos; Katarzyna Komosinska-Vassev; Lukasz Mencner; Krystyna Olczyk; Barbara Pilawa Journal: Evid Based Complement Alternat Med Date: 2016-08-03 Impact factor: 2.629